{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer's disease", "Groebke\u2013Blackburn\u2013Bienayme reaction", "Imidazopyridines", "Molecular docking", "Phthalimide", "\u03b2-Secretase inhibitor"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28728105", "DateCompleted": {"Year": "2017", "Month": "10", "Day": "02"}, "DateRevised": {"Year": "2017", "Month": "10", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "06", "Day": "24"}], "Language": ["eng"], "ELocationID": ["10.1016/j.ejmech.2017.06.040", "S0223-5234(17)30486-5"], "Journal": {"ISSN": "1768-3254", "JournalIssue": {"Volume": "138", "PubDate": {"Year": "2017", "Month": "Sep", "Day": "29"}}, "Title": "European journal of medicinal chemistry", "ISOAbbreviation": "Eur J Med Chem"}, "ArticleTitle": "Discovery of imidazopyridines containing isoindoline-1,3-dione framework as a new class of BACE1 inhibitors: Design, synthesis and SAR analysis.", "Pagination": {"StartPage": "729", "EndPage": "737", "MedlinePgn": "729-737"}, "Abstract": {"AbstractText": ["Alzheimer's disease is characterized by chronic neurodegeneration leading to dementia. The main cause of neurodegeneration is considered to be the accumulation of amyloid-\u03b2. Inhibiting BACE1 is a well-studied approach to lower the burden of amyloid-\u03b2 aggregates. We designed a series of imidazopyridines-based compounds bearing phthalimide moieties as inhibitors of BACE1. The compounds 8a-o were synthesized by the Groebke-Blackburn-Bienaym\u00e9 three-component reaction of heteroaromatic amidines, aldehydes and isocyanides. Evaluating the BACE1 inhibitory effects of the synthesized compounds revealed that introducing an aminocyclohexyl moiety in the imidazopyridine core resulted in a significant improvement in its BACE1 inhibitory potential. In this regard, compound 8e was the most potent against BACE1 with an IC<sub>50</sub> value of 2.84 (\u00b10.95) \u03bcM. Molecular docking revealed that the nitrogen atom of imidazopyridines and the oxygen atom of the phenoxypropyl linker were involved in hydrogen bound interactions with Asp228 and Asp32 of BACE1 active site, respectively. The phthalimide moiety oriented toward the flap pocket and interacted with phe108, lle110, Trp115, Ile118 through van der Waal's and hydrophobic interactions. These findings demonstrate that imidazopyridines-based compounds bearing phthalimide moiety have the potential to decrease amyloid-\u03b2 levels and ameliorate the symptoms of Alzheimer's disease."], "CopyrightInformation": "Copyright \u00a9 2017. Published by Elsevier Masson SAS."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chemistry, College of Science, University of Tehran, PO Box 14155-6455, Tehran, Iran."}], "LastName": "Azimi", "ForeName": "Sara", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chemistry, College of Science, University of Tehran, PO Box 14155-6455, Tehran, Iran."}], "LastName": "Zonouzi", "ForeName": "Afsaneh", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Firuzi", "ForeName": "Omidreza", "Initials": "O"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Iraji", "ForeName": "Aida", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran; Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Saeedi", "ForeName": "Mina", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: mahdavi.chem@gmail.com."}], "LastName": "Mahdavi", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Electronic address: edrakin@sums.ac.ir."}], "LastName": "Edraki", "ForeName": "Najmeh", "Initials": "N"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "France", "MedlineTA": "Eur J Med Chem", "NlmUniqueID": "0420510", "ISSNLinking": "0223-5234"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Imidazoles"}, {"RegistryNumber": "0", "NameOfSubstance": "Isoindoles"}, {"RegistryNumber": "0", "NameOfSubstance": "Protease Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Pyridines"}, {"RegistryNumber": "0", "NameOfSubstance": "imidazopyridine"}, {"RegistryNumber": "0", "NameOfSubstance": "isoindoline-1,3-dione"}, {"RegistryNumber": "EC 3.4.-", "NameOfSubstance": "Amyloid Precursor Protein Secretases"}, {"RegistryNumber": "EC 3.4.23.-", "NameOfSubstance": "Aspartic Acid Endopeptidases"}, {"RegistryNumber": "EC 3.4.23.46", "NameOfSubstance": "BACE1 protein, human"}], "MeshHeadingList": [{"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Amyloid Precursor Protein Secretases"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Aspartic Acid Endopeptidases"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Drug Discovery"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Imidazoles"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Isoindoles"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Protease Inhibitors"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Pyridines"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2017", "Month": "3", "Day": "6"}, {"Year": "2017", "Month": "5", "Day": "31"}, {"Year": "2017", "Month": "6", "Day": "22"}, {"Year": "2017", "Month": "7", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "10", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "7", "Day": "21", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["28728105", "10.1016/j.ejmech.2017.06.040", "S0223-5234(17)30486-5"]}}]}